Why You Should Look at Madison Square Garden Company's Stock on Monday?
Results Report In Focus: Amgen, Cytokinetics, Biogen Idec, Cosi, Sigma Designs, Geron, Halozyme Therapeutics | Galaxy Stocks Subscribe to RSS



Results Report In Focus: Amgen, Cytokinetics, Biogen Idec, Cosi, Sigma Designs, Geron, Halozyme Therapeutics

Amgen, Inc. (NASDAQ:AMGN) and Cytokinetics, Inc. (NASDAQ:CYTK) extended Amgen’s license for omecamtiv mecarbil in addition to related compounds to include Japan, with Amgen approving to give Cytokinetics $25M as part of an expanded license deal.

Shares of Amgen, Inc. (NASDAQ:AMGN) opened at $98.97 with 749.98 million outstanding shares and touched its highest price of $99.50 during the day and then finished at $96.37 by scoring -1.59%. In the whole session, it traded on volume of 2.57 million shares which turned lower than its average volume.

Cytokinetics, Inc. (NASDAQ:CYTK) stock hit highest price at $1.49, beginning with a price of $1.46 and reported a gain of +10.24% to the closed at $1.40 with a day range of $1.29-$1.49. The total market capitalization remained $205.08 million, total volume of 6.34 million shares held in the session was surprisingly higher than its average volume of 974,799 shares.

Citi cutes its rating for Biogen Idec Inc. (NASDAQ:BIIB) to neutral amid valuation concerns, amid other factors. As its shares plunged -7.39%

Biogen Idec Inc. (NASDAQ:BIIB) begun last trade with a price of $217.70 and throughout the trading session climbed at a high of $218.90. The day-trade ended with a dropped of -7.39% to $206.55. The stock is going forward its 52 week low with 56.47% and lagging behind from its 52 week high price with -14.87%. BIIB last month stock price volatility remained 3.56%.

Fast-casual restaurant chain Cosi Inc (NASDAQ:COSI) released a restructuring plan whereas also naming Executive Chairman Stephen Edwards as its new CEO and president, after the resignation of Carin Stutz.

Cosi Inc (NASDAQ:COSI) stock hit highest price at $2.40, beginning with a price of $2.29 and reported a loss of -11.86% to the closed at $2.08 with a day range of $2.06-$2.40. The total market capitalization remained $38.07 million, total volume of 223,393 shares held in the session was surprisingly higher than its average volume of 120,446 shares.

Sigma Designs Inc (NASDAQ:SIGM) reported on Wednesday that its Q1 net loss of $4.5M or $0.13 a share, lower than $13.7M or $0.42 a share in the similar quarter previous year.

Sigma Designs Inc (NASDAQ:SIGM) stock hit highest price at $5.30, beginning with a price of $5.20 and reported a gain of +1.16% to the closed at $5.24 with a day range of $5.11-$5.30. The stock is going forward its 52 week low with 21.86% and lagging behind from its 52 week high price with -27.22%.

Geron Corporation (NASDAQ:GERN) stock hit highest price at $1.16, beginning with a price of $1.16 and reported a loss of -0.87% to the closed at $1.14 with a day range of $1.13-$1.16. The total market capitalization remained $148.69 million, total volume of 442,298 shares held in the session was surprisingly lower than its average volume of 691,731 shares.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) begun last trade with a price of $6.70 and throughout the trading session climbed at a high of $6.73. The day-trade ended with a decreased of -3.61% to $6.40. The stock is going forward its 52 week low with 25.27% and lagging behind from its 52 week high price with -61.87%. HALO last month stock price volatility remained 4.65%.


Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here

0 comments

Other articlesgo to homepage

RADA Electronic Industries (RADA) Multi-Mission Hemispheric Radar Deal, Capnia (CAPN) Highly Rated

RADA Electronic Industries (RADA) Multi-Mission Hemispheric Radar Deal, Capnia (CAPN) Highly Rated

Shares of RADA Electronic Industries Ltd. (Nasdaq:RADA) soared on Monday’s trading session, currently exchanging hands for about $3.13, up $1.44 (or +85.21%), after the company said that Lockheed Martin Space Systems Company, one of the four major business divisions of Lockheed Martin Corp. (NYSE:LMT), has selected RADA’s Multi-Mission Hemispheric Radar to use it in combination with other sensors in laser weapon

Perspective Angle Effect in Stocks: Ctrip.com International (CTRP), Lennar (LEN), Owens Corning (OC)

Perspective Angle Effect in Stocks: Ctrip.com International (CTRP), Lennar (LEN), Owens Corning (OC)

The price of Ctrip.com International Ltd. (Nasdaq:CTRP) stock soared $11.44 (or +24.79%) to $57.58, and 22,214,020 of its shares were traded on Friday’s market activity, following the release of the company’s fourth quarter 2014 financial results, highlighted by net revenues of $308 million, representing a 33% year over year and exceeding Ctrip’s net revenue guidance of 30% versus

Prothena Corporation (PRTA) Skyrockets on Parkinson’s Disease Hope, Rally Software Development (RALY) Rallies on Expectations

Prothena Corporation (PRTA) Skyrockets on Parkinson’s Disease Hope, Rally Software Development (RALY) Rallies on Expectations

Shares of Prothena Corporation plc (Nasdaq:PRTA) skyrocketed on Friday’s trading session, currently trading for about $38.13, up $8.90 (or +30.46%), after the company reported positive data for its monoclonal antibody PRX002 in a Phase 1 single ascending dose study, bringing a new hope for Parkinson’s disease patients. In the study, PRX002 was safe and well-tolerated, and

Amicus Therapeutics (FOLD) Rises on Successful Regulatory Interactions, Coronado Biosciences (CNDO) Soars on Portfolio Expansion

Amicus Therapeutics (FOLD) Rises on Successful Regulatory Interactions, Coronado Biosciences (CNDO) Soars on Portfolio Expansion

Shares of Amicus Therapeutics, Inc. (Nasdaq:FOLD) touched a new 52-week high of $13.20 in early trading on Tuesday, after the it reported recent ‘positive’ regulatory interactions with health officials in both the U.S. (FDA) and EU (European Rapporteurs), to discuss the approval pathways for its Fabry disease therapy, migalastat. FOLD stock is currently trading for about $12.77,

Crown Equity Holdings Inc. Issues Letter to Shareholders

Crown Equity Holdings Inc. Issues Letter to Shareholders

Las Vegas, NV, October 13, 2014 – (CRWE Press Release) – Crown Equity Holdings Inc., (PINKSHEET: CRWE) today release Shareholder Update. [Special Video Presentation:]   To our shareholders, Thus far in 2014, Crown Equity Holdings Inc., has enlarged its web presence with publishing over 1400 community focused, local news and information online sites combined with

read more

Sign Up*

Receive Our Newsletter!

 



 

 

Contacts and information

Social networks

Most popular categories

© 2015 Crown Equity Holdings Inc. All rights reserved.
%d bloggers like this: